tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Kontafarma China Holdings Delays Circular Dispatch for Beijing Project

Story Highlights
Kontafarma China Holdings Delays Circular Dispatch for Beijing Project

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Kontafarma China Holdings Ltd ( (HK:1312) ) is now available.

Kontafarma China Holdings Ltd announced a delay in the dispatch of a circular related to a discloseable and connected transaction concerning the Beijing Construction Contract for the Beijing R&D Complex Project. The delay is due to the need for additional time to finalize certain information, and the company is seeking a waiver from the Stock Exchange to extend the dispatch date to on or before 30 September 2025.

More about Kontafarma China Holdings Ltd

Average Trading Volume: 1,162,576

Technical Sentiment Signal: Sell

Current Market Cap: HK$156.2M

For detailed information about 1312 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1